Showing Results : 1-1 of 1
Sort By :


  • Journal of Hepatocellular Carcinoma: 2023, vol: 10, issue:
  • 1)- Yunfei Zhang, Ruofan Sheng, Chun Yang, Yongming Dai, Mengsu Zeng. The Feasibility of Using Tri-Exponential Intra-Voxel Incoherent Motion DWI for Identifying the Microvascular Invasion in Hepatocellular Carcinoma. Journal of hepatocellular carcinoma. 2023, 10: 1659-1671
    Cited : 3
    Read More
  • 2)- Jincheng Xiao, Jing Wang, Chaoqun Zhou, Junpeng Luo. Development and Validation of a Propionate Metabolism-Related Gene Signature for Prognostic Prediction of Hepatocellular Carcinoma. Journal of hepatocellular carcinoma. 2023, 10: 1673-1687
    Cited : 1
    Read More
  • 3)- Valentina Zanuso, Angelo Pirozzi, Rita Balsano, Tiziana Pressiani, Lorenza Rimassa. Safety and Efficacy of Atezolizumab and Bevacizumab Combination as a First Line Treatment of Advanced Hepatocellular Carcinoma. Journal of hepatocellular carcinoma. 2023, 10: 1689-1708
    Cited : 3
    Read More
  • 4)- Bingran Yu, Ning Zhang, Yun Feng, Yongfa Zhang, Ti Zhang, Lu Wang. Hepatectomy After Conversion Therapy with Hepatic Arterial Infusion Chemotherapy, Tyrosine Kinase Inhibitors and Anti-PD-1 Antibodies for Initially Unresectable Hepatocellular Carcinoma. Journal of hepatocellular carcinoma. 2023, 10: 1709-1721
    Cited : 2
    Read More
  • 5)- Jingxin Yan, Yonghao Wen, Manjun Deng, Bin Ye, Xinlian Liu, Lushun Zhang. Transarterial Chemoembolization Plus Sorafenib versus Transarterial Chemoembolization Alone for Advanced Hepatocellular Carcinoma: An Umbrella Review of Meta-Analyses and Systematic Reviews. Journal of hepatocellular carcinoma. 2023, 10: 1723-1733
    Cited : 2
    Read More
  • 6)- Bingran Yu, Ning Zhang, Yun Feng, Yongfa Zhang, Ti Zhang, Lu Wang. Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibodies with Hepatic Arterial Infusion Chemotherapy or Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma. Journal of hepatocellular carcinoma. 2023, 10: 1735-1748
    Cited : 2
    Read More
  • 7)- Shusheng Lin, Yi Cao, Ke Zhu, Caini Yang, Xiangping Zhu, Honghua Zhang, Rui Zhang. Identification of a Novel Prognostic Signature Based on N-Linked Glycosylation and Its Correlation with Immunotherapy Response in Hepatocellular Carcinoma. Journal of hepatocellular carcinoma. 2023, 10: 1749-1765
    Cited : 4
    Read More
  • 8)- Renhou Zhi, Pengfei Hao, Weibin Li, Haoliang Zhao. Expression of CKS2 in Hepatocellular Carcinoma: Correlation with Survival Outcomes and Immune Microenvironment. Journal of hepatocellular carcinoma. 2023, 10: 1767-1784
    Cited : 3
    Read More
  • 9)- Shanshan Chen, Youjia Duan, Yongchao Zhang, Long Cheng, Liang Cai, Xiaopu Hou, Wei Li. Associations Between Single Nucleotide Polymorphisms of Hypoxia-Related Genes and Capsule Formation in Hepatocellular Carcinoma. Journal of hepatocellular carcinoma. 2023, 10: 1785-1797
    Cited : 0
    Read More
  • 10)- Shu-Qun Li, Jun-Yi Wu, Jia-Yi Wu, Huang Xie, Jin-Hai Li, Zhen-Xin Zeng, Yang-Kai Fu, De-Yi Liu, Han Li, Wei-Zhao Chen, Jing-Yao Huang, Mao-Lin Yan. Transarterial Chemoembolization Plus Lenvatinib and PD-1 Inhibitors for Hepatocellular Carcinoma with Main Trunk Portal Vein Tumor Thrombus: A Multicenter Retrospective Study. Journal of hepatocellular carcinoma. 2023, 10: 1799-1811
    Cited : 8
    Read More
  • 11)- Qiumei Lin, Zongwei Jiang, Dan Mo, Fengfei Liu, Yuling Qin, Yihua Liang, Yuchen Cheng, Hao Huang, Min Fang. Beta2-Microglobulin as Predictive Biomarkers in the Prognosis of Hepatocellular Carcinoma and Development of a New Nomogram. Journal of hepatocellular carcinoma. 2023, 10: 1813-1825
    Cited : 1
    Read More
  • 12)- Meng-Chao Luo, Jia-Yi Wu, Jun-Yi Wu, Zhong-Tai Lin, Yi-Nan Li, Zhen-Xin Zeng, Shao-Ming Wei, Mao-Lin Yan. Early Tumor Marker Response Predicts Treatment Outcomes in Patients with Unresectable Hepatocellular Carcinoma Receiving Combined Lenvatinib, Immune Checkpoint Inhibitors, and Transcatheter Arterial Chemoembolization Therapy. Journal of hepatocellular carcinoma. 2023, 10: 1827-1837
    Cited : 2
    Read More
  • 13)- Jing Yang, Shuang Liang, Huahui Liu, Cai Hu, Sainan Guan, Haiyu Kang, Erjiao Xu, Ronghua Yan. Efficacy and Safety of Microwave Ablation Assisted by Ultrasound Fusion Imaging for Primary and Secondary Liver Cancers with a Diameter of 3-7 Cm. Journal of hepatocellular carcinoma. 2023, 10: 1839-1848
    Cited : 2
    Read More
  • 14)- Teng Long, Zhoutian Yang, Huilan Zeng, Weijie Wu, Zhiwen Hu, Zhenyun Yang, Dandan Hu, Zhongguo Zhou, Minshan Chen, Yaojun Zhang. Comparable Clinical Outcomes Between Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy Combined with Tyrosine Kinase Inhibitors and PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma. Journal of hepatocellular carcinoma. 2023, 10: 1849-1859
    Cited : 3
    Read More
  • 15)- Qin Shi, Peng Huang, Zihan Zhang, Wen Zhang, Lingxiao Liu, Zhiping Yan. Hepatocellular Carcinoma with Radiological Progression: Lenvatinib Plus PD-1 Inhibitor Combined with Microwave Ablation and Synchronous Transarterial Chemoembolization. Journal of hepatocellular carcinoma. 2023, 10: 1861-1871
    Cited : 0
    Read More
  • 16)- Hsiao-Mei Hsu, Hsin-I Tsai, Wei-Chen Lee, Chih-Chi Wang, Ming-Chin Yu, Shi-Ming Lin, Chun-Yen Lin, Chi-Huan Wu, Chao-Wei Lee. The Extended Surgical Concepts for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors. Journal of hepatocellular carcinoma. 2023, 10: 1873-1880
    Cited : 3
    Read More
  • 17)- Xinyue Tu, Jie Zhang, Minjun Li, Fei Lu, Ting Wang, Wenfeng Gong, Bangde Xiang. Development and Validation of a Prediction Model for Hepatitis B Virus-Related Hepatocellular Carcinoma Patients Receiving Postoperative Adjuvant Transarterial Chemoembolization. Journal of hepatocellular carcinoma. 2023, 10: 1881-1895
    Cited : 1
    Read More
  • 18)- Yanjie Yang, Nan Du, Jingqin Ma, Zhijie Peng, Bo Zhou, Jiaze Yu, Xin Zhou, Wen Zhang, Zhiping Yan. Efficacy and Safety of Transarterial Chemoembolization with a Three-Stage Mixed Chemoembolic Regimen for Large Unresectable Hepatocellular Carcinoma. Journal of hepatocellular carcinoma. 2023, 10: 1897-1910
    Cited : 1
    Read More
  • 19)- Zunirah Ahmed, Sunyoung S Lee, David W Victor, Sudha Kodali. Evidence to Date: Clinical Utility of Tremelimumab in the Treatment of Unresectable Hepatocellular Carcinoma. Journal of hepatocellular carcinoma. 2023, 10: 1911-1922
    Cited : 3
    Read More
  • 20)- Leonardo G Da Fonseca, Victor Junji Yamamoto, Mateus Trinconi Cunha, Giovanna Sawaya Torre, Raphael L C Araujo, Gilton Marques Fonseca, Andre Tsin Chih Chen, Aline Lopes Chagas, Paulo Herman, Venancio Avancini Ferreira Alves, Flair Jose Carrilho. Treatment Outcomes in Patients with Advanced Fibrolamellar Hepatocellular Carcinoma Under Systemic Treatment: Analysis of Clinical Characteristics, Management, and Radiomics. Journal of hepatocellular carcinoma. 2023, 10: 1923-1933
    Cited : 0
    Read More
  • 21)- Ali Riza Koksal, Nergiz Ekmen, Yucel Aydin, Kelley Nunez, Tyler Sandow, Molly Delk, Martin Moehlen, Paul Thevenot, Ari Cohen, Srikanta Dash. A Single-Step Immunocapture Assay to Quantify HCC Exosomes Using the Highly Sensitive Fluorescence Nanoparticle-Tracking Analysis. Journal of hepatocellular carcinoma. 2023, 10: 1935-1954
    Cited : 1
    Read More
  • 22)- Giulia Francesca Manfredi, Ciro Celsa, Chloe John, Charlotte Jones, Nicole Acuti, Bernhard Scheiner, Claudia Angela Maria Fulgenzi, James Korolewicz, Matthias Pinter, Alessandra Gennari, Francesco A Mauri, Mario Pirisi, Rosalba Minisini, Federica Vincenzi, Michela Burlone, Cristina Rigamonti, Matteo Donadon, Giuseppe Cabibbo, Antonio D'Alessio, David James Pinato. Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma. Journal of hepatocellular carcinoma. 2023, 10: 1955-1971
    Cited : 3
    Read More
  • 23)- Michal Mauda-Havakuk, Natalie M Hawken, Joshua W Owen, Andrew S Mikhail, Matthew F Starost, Baktiar Karim, Paul G Wakim, Olga L Franco-Mahecha, Andrew L Lewis, William F Pritchard, John W Karanian, Bradford J Wood. Immune Effects of Cryoablation in Woodchuck Hepatocellular Carcinoma. Journal of hepatocellular carcinoma. 2023, 10: 1973-1990
    Cited : 0
    Read More
  • 24)- Huamei Wei, Lizheng Huang, Qi Lu, Zheng Huang, Yanyan Huang, Zuoming Xu, Wenchuan Li, Jian Pu. N-Methyladenosine-Modified LEAWBIH Drives Hepatocellular Carcinoma Progression through Epigenetically Activating Wnt/β-Catenin Signaling. Journal of hepatocellular carcinoma. 2023, 10: 1991-2007
    Cited : 3
    Read More
  • 25)- Qiuying Qin, Xiaoxuan Kou, Yuanyuan Zheng, Fei Zhou, Xiaoyong Zhang, Hongyan Liu. Early C-reactive Protein Kinetics Predict Response to Immune Checkpoint Blockade in Unresectable Hepatocellular Carcinoma. Journal of hepatocellular carcinoma. 2023, 10: 2009-2019
    Cited : 2
    Read More
  • 26)- Yanjun Gao, Yingge Li, Zheming Liu, Yi Dong, Siqi Yang, Bin Wu, Mengxia Xiao, Chen Chen, Yingmei Wen, Lei Chen, Haijuan Jiang, Yi Yao. AHSA1 Regulates Hepatocellular Carcinoma Progression via the TGF-β/Akt-Cyclin D1/CDK6 Pathway. Journal of hepatocellular carcinoma. 2023, 10: 2021-2036
    Cited : 0
    Read More
  • 27)- Guangxin Li, Ying Zhao, Keren Li, Shizhong Yang, Canhong Xiang, Jiyong Song, Yanmei Yang, Gong Li, Jiahong Dong. Effectiveness and Safety of the PD-1 Inhibitor Lenvatinib Plus Radiotherapy in Patients with HCC with Main PVTT: Real-World Data from a Tertiary Centre. Journal of hepatocellular carcinoma. 2023, 10: 2037-2048
    Cited : 1
    Read More
  • 28)- Yongqiang Xiao, Guoqing Zhu, Jin Xie, Laihui Luo, Wei Deng, Liucong Lin, Jiahao Tao, Zhigao Hu, Renfeng Shan. Pretreatment Neutrophil-to-Lymphocyte Ratio as Prognostic Biomarkers in Patients with Unresectable Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and Camrelizumab. Journal of hepatocellular carcinoma. 2023, 10: 2049-2058
    Cited : 3
    Read More
  • 29)- Hong-Mei Li, Wei Huang, Chao Hu, Zi-Shu Zhang, Yu-Dong Xiao, Tian-Cheng Wang. Prognostic Factors for Patients with Proliferative Hepatocellular Carcinoma After Liver Resection. Journal of hepatocellular carcinoma. 2023, 10: 2059-2071
    Cited : 0
    Read More
  • 30)- Ze-Xin Hu, Xiao-Yang Xu, Ze Wang, Jin-Tao Huang, Wan-Ci Li, Shuai Zhang, Jian Shen, Bin-Yan Zhong, Xiao-Li Zhu. Prognosis Prediction of CRAFITY Score in HCC Undergoing TACE Combined with PD-(L)1 Inhibitors and Molecular Targeted Therapy. Journal of hepatocellular carcinoma. 2023, 10: 2073-2082
    Cited : 0
    Read More
  • 31)- Zishuai Li, Zihan Zhang, Letian Fang, Jiayi Zhao, Zheyun Niu, Hongsen Chen, Guangwen Cao. Tumor Microenvironment Composition and Related Therapy in Hepatocellular Carcinoma. Journal of hepatocellular carcinoma. 2023, 10: 2083-2099
    Cited : 5
    Read More
  • 32)- . Erratum: Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma [Corrigendum]. Journal of hepatocellular carcinoma. 2023, 10: 2101-2102
    Cited : 0
    Read More
  • 33)- Hai-Feng Liu, Yang Lu, Qing Wang, Yu-Jie Lu, Wei Xing. Machine Learning-Based CEMRI Radiomics Integrating LI-RADS Features Achieves Optimal Evaluation of Hepatocellular Carcinoma Differentiation. Journal of hepatocellular carcinoma. 2023, 10: 2103-2115
    Cited : 5
    Read More
  • 34)- Zhikai Zheng, Jiongliang Wang, Tianqing Wu, Minrui He, Juncheng Wang, Yangxun Pan, Jinbin Chen, Dandan Hu, Li Xu, Yaojun Zhang, Minshan Chen, Zhongguo Zhou. Tenofovir versus Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma After FOLFOX-Hepatic Arterial Infusion Chemotherapy. Journal of hepatocellular carcinoma. 2023, 10: 2117-2132
    Cited : 1
    Read More
  • 35)- Tianqing Wu, Zhikai Zheng, Jiongliang Wang, Minrui He, Juncheng Wang, Yangxun Pan, Jinbin Chen, Dandan Hu, Yaojun Zhang, Li Xu, Minshan Chen, Zhongguo Zhou. Systemic Inflammation Score Using Pretherapeutic Inflammatory Markers to Predict Prognosis for Hepatocellular Carcinoma Patients After Hepatic Arterial Infusion Chemotherapy. Journal of hepatocellular carcinoma. 2023, 10: 2133-2145
    Cited : 1
    Read More
  • 36)- Sally Tran, Biyao Zou, Leslie Kam, KeeSeok Lee, Daniel Q Huang, Linda Henry, Ramsey Cheung, Mindie H Nguyen. Updates in Characteristics and Survival Rates of Hepatocellular Carcinoma in a Nationwide Cohort of Real-World US Patients, 2003-2021. Journal of hepatocellular carcinoma. 2023, 10: 2147-2158
    Cited : 3
    Read More
  • 37)- . Erratum: The Feasibility of Using Tri-Exponential Intra-Voxel Incoherent Motion DWI for Identifying the Microvascular Invasion in Hepatocellular Carcinoma [Corrigendum]. Journal of hepatocellular carcinoma. 2023, 10: 2159-2160
    Cited : 0
    Read More
  • 38)- Jia-Yi Wu, Jun-Yi Wu, De-Yi Liu, Han Li, Shao-Wu Zhuang, Bin Li, Jian-Yin Zhou, Jing-Yao Huang, Zhi-Bo Zhang, Shu-Qun Li, Mao-Lin Yan, Yao-Dong Wang. Clinical Complete Response After Conversion Therapy for Unresectable Hepatocellular Carcinoma: Is Salvage Hepatectomy Necessary? Journal of hepatocellular carcinoma. 2023, 10: 2161-2171
    Cited : 2
    Read More
  • 39)- Kailin Xing, Xinyu Bian, Dongmin Shi, Shuangshuang Dong, Hongxin Zhou, Shuxiu Xiao, Jinjin Bai, Weizhong Wu. miR-612 Enhances RSL3-Induced Ferroptosis of Hepatocellular Carcinoma Cells via Mevalonate Pathway. Journal of hepatocellular carcinoma. 2023, 10: 2173-2185
    Cited : 8
    Read More
  • 40)- Liang Zhang, Jun Wang, Yang Li, Leina Hou, Jianguo Xia, Jialin Shen. Implanting Iodine-125 Seed Strand Inside the Portal Vein Stent: An Improved Approach to Endovascular Brachytherapy for Treatment of Patients with Hepatocellular Carcinoma and Main Portal Vein Tumor Thrombus. Journal of hepatocellular carcinoma. 2023, 10: 2187-2196
    Cited : 1
    Read More
  • 41)- Yanchao Xu, Yunzheng Li, Yanjun Lu, Weihong Wang, Zhaowu Lian, Zijie Wu, Binghua Li, Decai Yu. Liver Regeneration-Related Genes of Nontumor Liver Tissues Predict the Prognosis of Patients with Hepatocellular Carcinoma. Journal of hepatocellular carcinoma. 2023, 10: 2197-2209
    Cited : 0
    Read More
  • 42)- Hao-Huan Tang, Ming-Qing Zhang, Zi-Chen Zhang, Chen Fan, Yong Jin, Wei-Dong Wang. The Safety and Efficacy of Hepatic Arterial Infusion Chemotherapy Combined with PD-(L)1 Inhibitors and Molecular Targeted Therapies for the Treatment of Intermediate and Advanced Hepatocellular Carcinoma Unsuitable for Transarterial Chemoembolization. Journal of hepatocellular carcinoma. 2023, 10: 2211-2221
    Cited : 2
    Read More
  • 43)- Zhi-Hao Zhao, Chao Jiang, Qing-Yuan Wu, Guo-Yue Lv, Meng Wang. Nomogram for Estimation of Acute Liver Failure Risk in Spontaneous Ruptured Hepatocellular Carcinoma. Journal of hepatocellular carcinoma. 2023, 10: 2223-2237
    Cited : 0
    Read More
  • 44)- Lin Xu, Dongxu Zhao, Pengcheng Tian, Jiaan Ding, Zhengyu Jiang, Guanyin Ni, Zhongheng Hou, Caifang Ni. Development and Validation of a Prognostic Model for Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma Based on Preoperative Serum Prealbumin. Journal of hepatocellular carcinoma. 2023, 10: 2239-2250
    Cited : 0
    Read More
  • 45)- Jihye Lim, Hyeon-Gi Jeon, Yeonjoo Seo, Moonjin Kim, Ja Un Moon, Se Hyun Cho. Survival Prediction Model for Patients with Hepatocellular Carcinoma and Extrahepatic Metastasis Based on XGBoost Algorithm. Journal of hepatocellular carcinoma. 2023, 10: 2251-2263
    Cited : 1
    Read More
  • 46)- Benjian Gao, Fengyi Yang, Dongning Zheng, Shuai Hu, Jie Liu, Hong Liu, Yongfa Liu, LinXin Liu, Rui Wang, Yi Zhao, Cheng Cui, Cheng Fang, Jin Yang, Song Su, Yunwei Han, Xiaoli Yang, Bo Li. Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis. Journal of hepatocellular carcinoma. 2023, 10: 2265-2276
    Cited : 3
    Read More
  • 47)- Thi Phuong Thao Hoang, Philipp Schindler, Nikolaus Börner, Max Masthoff, Mirjam Gerwing, Philippa von Beauvais, Enrico N De Toni, Christian M Lange, Jonel Trebicka, Haluk Morgül, Max Seidensticker, Jens Ricke, Andreas Pascher, Markus Guba, Michael Ingrisch, Moritz Wildgruber, Osman Öcal. Imaging-Derived Biomarkers Integrated with Clinical and Laboratory Values Predict Recurrence of Hepatocellular Carcinoma After Liver Transplantation. Journal of hepatocellular carcinoma. 2023, 10: 2277-2289
    Cited : 0
    Read More
  • 48)- Yijie Wang, Weixiang Weng, Ruiming Liang, Qian Zhou, Hangtong Hu, Mingde Li, Lida Chen, Shuling Chen, Sui Peng, Ming Kuang, Han Xiao, Wei Wang. Predicting T Cell-Inflamed Gene Expression Profile in Hepatocellular Carcinoma Based on Dynamic Contrast-Enhanced Ultrasound Radiomics. Journal of hepatocellular carcinoma. 2023, 10: 2291-2303
    Cited : 2
    Read More
  • 49)- Yichen Peng, Xia Wu, Yurong Zhang, Yue Yin, Xianglin Chen, Ding Zheng, Jing Wang. An Overview of Traditional Chinese Medicine in the Treatment After Radical Resection of Hepatocellular Carcinoma. Journal of hepatocellular carcinoma. 2023, 10: 2305-2321
    Cited : 3
    Read More
  • 50)- Xinxin Wang, Yanyan Yu, Yuqing Tao, Yueqi Wang, Chunhui Zhang, Yali Cui, Yang Zhou. Clinical-Radiological Characteristic for Predicting Ultra-Early Recurrence After Liver Resection in Solitary Hepatocellular Carcinoma Patients. Journal of hepatocellular carcinoma. 2023, 10: 2323-2335
    Cited : 0
    Read More
 
 


Journal List
Links
Content Links
About Us

0